Pharma News
Stay current with the latest pharma news! PharmaLeaders has everything you need to lead!
-
JP Morgan Healthcare Conference Update
As the healthcare industry evolves at a breathtaking pace, the JP Morgan Healthcare Conference remains a pivotal event, showcasing groundbreaking…
Read More » -
Amgen Revolutionizes Drug Discovery with NVIDIA’s AI Technology and Human Genome Insights
Amgen, a global leader in biotechnology, is pioneering the use of Generative AI in drug discovery, leveraging one of the…
Read More » -
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™
So 2024 is starting off with a digital patient experience milestone from industry giant Eli Lilly. As we’ve written about…
Read More » -
Innovating Ophthalmology: A Dialogue with Azura’s CEO
As Azura Ophthalmics strides forward in the field of ophthalmology, we had the opportunity to sit down with Marc Gleeson,…
Read More » -
Court Upholds FTC Decision to Block IQVIA-DeepIntent Merger, Safeguarding Competition in Pharma Programmatic Advertising
In a significant development for the pharmaceutical industry, a U.S. court affirmed the Federal Trade Commission’s decision to halt the…
Read More » -
Pfizer Closes $43 Billion Seagen Deal, Overhauls Commercial Structure Amid Regulatory Clearance
Pfizer, the New York-based pharmaceutical giant, is set to complete its $43 billion acquisition of cancer drugmaker Seagen this Thursday,…
Read More » -
Non-Opioid Pain Relief: Vertex’s New Drug Promises Brighter Future for Diabetics with Nerve Pain
Vertex Pharmaceuticals is at the forefront of a significant medical breakthrough with its latest non-opioid painkiller, offering new hope for…
Read More » -
CVS Health Innovates Prescription Drug Pricing with Transparent Reimbursement Model
The drug price transparency “contagion” that Mark Cuban started with his Cost Plus Drug company continues to spread. In a…
Read More » -
Johnson & Johnson Projects Robust Growth in 2024: Insights and Analysis
Johnson & Johnson this week announced an optimistic revenue growth forecast of 5% to 6% for the coming year. This…
Read More » -
Pfizer discontinues twice daily weight loss pill due to high rates of adverse side effects
Pfizer announced on Friday that it would stop developing the twice-daily version of its experimental weight loss pill. While most common adverse events…
Read More »